Results 121 to 130 of about 122,678 (147)

Serological surveillance for SARS-CoV-2 antibodies among students, faculty and staff within a large university system during the pandemic. [PDF]

World J Virol
Pinheiro MG, Alves GGO, Conde MER, Costa SL, Sant'Anna RCS, Antunes IMF, Carneiro MC, Ronzei FS, Scaffo JC, Pinheiro FR, Andre LS, Povoa HC, Baltar VT, Giordani F, Hemerly ES, Alexandre GC, de Paula KC, Watanabe M, da Nóbrega ACL, Lobato JCP, Aguiar-Alves F.   +20 more
europepmc   +1 more source

Exploring distinct modes of inter-spike cross-linking for enhanced neutralization by SARS-CoV-2 antibodies. [PDF]

Nat Commun
Nan X, Li Y, Zhang R, Wang R, Lv N, Li J, Chen Y, Zhou B, Wang Y, Wang Z, Zhu J, Chen J, Li J, Chen W, Zhang Q, Shi X, Zhao C, Chen C, Liu Z, Zhao Y, Liu D, Wang X, Yan LT, Li T, Zhang L, Yang YR.   +25 more
europepmc   +1 more source

Estimation of world seroprevalence of SARS-CoV-2 antibodies. [PDF]

J Appl Stat
Lee K, Kim S, Jo S, Lee J.
europepmc   +1 more source

Prevalence of SARS-CoV-2 antibodies at the University hospital Heidelberg and correlation with SARS-CoV-2 incidence. [PDF]

Heliyon
Bundschuh C, Weidner N, Scholz TFM, Parthé S, Jost L, Gößnitzer E, Kräusslich HG.   +6 more
europepmc   +1 more source

Seroprevalence of SARS-CoV-2 antibodies among healthy blood donors: a systematic review and meta-analysis. [PDF]

BMC Public Health
Ukwishaka J, Mela CF, Aseneh JBN, Ettaj M, Ilboudo D, Danwang C, Samadoulougou S, Kirakoya-Samadoulougou F.   +7 more
europepmc   +1 more source

Hybrid Immunity and SARS-CoV-2 Antibodies: Results of the HEROES-RECOVER Prospective Cohort Study. [PDF]

Clin Infect Dis
Romine JK, Li H, Coughlin MM, Jones JM, Britton A, Tyner HL, Fuller SB, Bloodworth R, Edwards LJ, Etolue JN, Morrill TC, Newes-Adeyi G, Olsho LEW, Gaglani M, Fowlkes A, Hollister J, Bedrick EJ, Uhrlaub JL, Beitel S, Sprissler RS, Lyski Z, Porter CJ, Rivers P, Lutrick K, Caban-Martinez AJ, Yoon SK, Phillips AL, Naleway AL, Burgess JL, Ellingson KD.   +29 more
europepmc   +1 more source

SARS-CoV-2 antibodies in breast milk of women given one & two doses of COVID-19 vaccine. [PDF]

Indian J Med Res
Verma S, Yadav A, Venkatesh V, Jain A, Kumar M, Tripathi S, Singh R.   +6 more
europepmc   +1 more source

Waning of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in 2020: A 12-month-evaluation in three population-based European studies. [PDF]

PLoS One
Novelli S, Reinkemeyer C, Bulaev D, O'Sullivan MP, Snoeck CJ, Rauschenberger A, Manto C, Kolodkin A, Ghosh S, Satagopam V, le Chenadec J, Barthelemy K, Priet S, de Lamballerie X, Wieser A, Kroidl I, Vaillant M, Meyer L, Hoelscher M, Castelletti N, Krüger R, Warszawski J, ORCHESTRA Working Group.   +22 more
europepmc   +1 more source

SARS-CoV-2 antibodies in Colombian urban area: follow-up on occupational groups. [PDF]

Rev Cuid
Colmenares-Mejía CC, Quintero-Lesmes DC, Serrano NC, Meneses L, Salazar Acosta I, Idrovo ÁJ, Sanabria-Echeverry DY, Cordero Rebolledo H, Castillo V.   +8 more
europepmc   +1 more source

Seroprevalence of SARS-CoV-2 antibodies among children receiving primary care in Toronto, Ontario. [PDF]

Can J Public Health
Aglipay M, Kwong JC, Colwill K, Gringas AC, Tuite A, Mamdani M, Keown-Stoneman C, Birken C, Maguire J, TARGet Kids! Collaboration.   +9 more
europepmc   +1 more source